lactulose has been researched along with Esophageal Varices in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (21.43) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 5 (35.71) | 2.80 |
| Authors | Studies |
|---|---|
| Atkins, AR; Downes, M; Evans, RM; Huan, T; Loomba, R; Madamba, E; Oh, TG; Sharpton, SR; Wang, C; Yu, RT | 1 |
| Parikh, ND; Tapper, EB | 1 |
| Almaghrabi, M; Brar, S; Khan, MQ; Liang, A; Qumosani, K; Teriaky, A | 1 |
| Eder, MD; Hosseini, R; Kravetz, JD; Thomas, A; Varma, P | 1 |
| Beuers, UHW; Coenen, S; Coenraad, MJ; Cuperus, FJC; de Wit, K; Dijkgraaf, MGW; Kramer, M; Mostafavi, N; Nevens, F; Schaapman, JJ; Takkenberg, RB; Tjwa, ETTL; van Delden, OM; Verbeek, J | 1 |
| Baik, SK; Chang, Y; Cho, EJ; Cho, H; Cho, YY; Kang, SH; Kim, MY; Kim, YJ; Lee, JH; Lee, YB; Nam, JY; Yoo, JJ; Yoon, JH; Yu, SJ | 1 |
| Abdo-Francis, JM; Alla, SN; Camacho-Aguilera, J; Higuera-de-la-Tijera, F; Jiménez-Ponce, F; Pérez-Hernández, JL; Salas-Gordillo, F; Servín-Caamaño, AI | 1 |
| Khosravani, H; Perri, GA | 1 |
| Agrawal, A; Sarin, SK; Sharma, BC; Sharma, P | 1 |
| Klinken, E; MacQuillan, G | 1 |
| Bircher, J; Bührer, M; Franz, K; van Velthuijsen, JA | 1 |
| Bour, AV; Manuk'ian, GV; Shertsinger, AG; Umruzakov, IU | 1 |
| Dölle, W | 1 |
| Peglow, HJ; Ungeheuer, E | 1 |
4 review(s) available for lactulose and Esophageal Varices
| Article | Year |
|---|---|
Diagnosis and Management of Cirrhosis and Its Complications: A Review.
Topics: Adult; Ascites; Carvedilol; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Hepatorenal Syndrome; Humans; Lactulose; Liver Cirrhosis; Liver Neoplasms; Male; Muscle Cramp; Propranolol; Randomized Controlled Trials as Topic; Sodium Potassium Chloride Symporter Inhibitors; Terlipressin; United States | 2023 |
Primary prevention of hepatic encephalopathy post-TIPS: A systematic review and meta-analysis.
Topics: Albumins; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Lactulose; Primary Prevention; Rifaximin | 2023 |
Complications of end-stage liver disease.
Topics: Adrenergic beta-Antagonists; Anti-Bacterial Agents; Ascites; Bacterial Infections; Disease Management; End Stage Liver Disease; Esophageal and Gastric Varices; Esophagoscopy; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Hepatitis C, Chronic; Humans; Lactulose; Ligation; Middle Aged; Palliative Care; Paracentesis; Peritonitis | 2016 |
[Internal therapy of portal hypertension].
Topics: Anti-Bacterial Agents; Ascites; Bed Rest; Cathartics; Dietary Proteins; Esophageal and Gastric Varices; Hepatic Encephalopathy; Humans; Hypersplenism; Hypertension, Portal; Hypokalemia; Lactulose; Life Expectancy; Water-Electrolyte Balance | 1976 |
3 trial(s) available for lactulose and Esophageal Varices
| Article | Year |
|---|---|
Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled t
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Portasystemic Shunt, Transjugular Intrahepatic; Quality of Life; Rifaximin | 2020 |
Primary Prophylaxis to Prevent the Development of Hepatic Encephalopathy in Cirrhotic Patients with Acute Variceal Bleeding.
Topics: Acute Disease; Adult; Dipeptides; Double-Blind Method; Esophageal and Gastric Varices; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Rifaximin | 2018 |
Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose.
Topics: Acute Disease; Adult; Blood Transfusion; Chi-Square Distribution; Esophageal and Gastric Varices; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; India; Lactulose; Liver Cirrhosis; Male; Middle Aged; Proportional Hazards Models; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Young Adult | 2011 |
7 other study(ies) available for lactulose and Esophageal Varices
| Article | Year |
|---|---|
Gut metagenome-derived signature predicts hepatic decompensation and mortality in NAFLD-related cirrhosis.
Topics: Adult; Ascites; End Stage Liver Disease; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Metagenome; Non-alcoholic Fatty Liver Disease; Prospective Studies; Rifaximin; Severity of Illness Index | 2022 |
A Confusing Picture: Refractory Encephalopathy Complicating Nonalcoholic Steatohepatitis.
Topics: Aged; Brain; Confusion; Dyskinesias; Esophageal and Gastric Varices; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hyperammonemia; Hyperbilirubinemia; Hypertension, Portal; Lactulose; Liver Cirrhosis; Magnetic Resonance Imaging; Male; Non-alcoholic Fatty Liver Disease; Renal Veins; Rifaximin; Splenic Vein; Thrombocytopenia; Tomography, X-Ray Computed; Tremor; Vascular Diseases | 2020 |
Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Carcinoma, Hepatocellular; Esophageal and Gastric Varices; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Peritonitis; Recurrence; Retrospective Studies; Rifamycins; Rifaximin; Secondary Prevention | 2017 |
Lactulose a day keeps encephalopathy at bay.
Topics: Acute Disease; Blood Transfusion; Esophageal and Gastric Varices; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2011 |
[1st use of lactitol in the treatment of porto-systemic encephalopathy].
Topics: Esophageal and Gastric Varices; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Portacaval Shunt, Surgical; Postoperative Complications; Sugar Alcohols | 1982 |
[Enteral detoxication in patients with liver cirrhosis and bleeding from the esophageal and gastric varices ].
Topics: Combined Modality Therapy; Embolization, Therapeutic; Endoscopy, Digestive System; Esophageal and Gastric Varices; Gastric Lavage; Gastrointestinal Agents; Humans; Lactulose; Liver Cirrhosis; Recurrence; Sorption Detoxification; Treatment Outcome; Urea | 1997 |
[Measures in massive hemorrhages of esophageal varices].
Topics: Anti-Bacterial Agents; Arteriovenous Shunt, Surgical; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Lactulose; Malates; Steroids; Vascular Surgical Procedures; Vitamins | 1976 |